Arogat-P Eye Drop

Arogat-P Eye Drop is a combination of two medicines used in the treatment of bacterial eye infections. It stops the growth of microorganisms and kills the existing ones that cause the infection. It also blocks the release of certain chemical messengers that cause the eye red, swollen, and itchy.

Arogat-P Eye Drop is to be used only in the affected eye. Use it in the dose and duration as advised by the doctor. Read the label carefully for instruction before you use the medicine. Wash your hands before using this medicine. Do not use too much or too little. Use it in the exact dose as prescribed by the doctor or as instructed in the label.
Use of this medicine may cause burning sensation, stinging, and irritation at the application site. These are usually temporary and resolve with time. However, if they persist or get worse, inform your doctor. In case of accidental contact with your ears, nose, or mouth, immediately rinse it with water.
Inform your doctor if you have a known allergy to any of the ingredients in this medicine or if you are taking any other medication. It is advised not to drive or operate heavy machinery immediately after using this medicine as it may cause temporary blurring of vision and may affect your ability to drive.

• Treatment of Bacterial eye infections

Treatment of Bacterial eye infections
Arogat-P Eye Drop is used to treat bacterial infections of the eyes such as conjunctivitis or pink eye. It stops the growth of bacteria causing infection and helps relieve pain, swelling, redness, itching, or irritation in the eyes. Use it 2-3 times a day for at least a week or as prescribed by the doctor. Your symptoms might improve after using Arogat-P Eye Drop. However, make sure to complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of DR Mpred

• Stinging sensation
• Corneal inflammation
• Conjunctival irritation
• Increased lacrimation
• Papillary conjunctivitis

Severe side effects of DR Mpred

• Anaphylactic reaction
• Eyelid inflammation
• Breathlessness
• Eye itching
• Eye swelling
• Hypersensitivity
• Nausea
• Itching
• Red spots or bumps
• Blurred vision
• Increased intraocular pressure
• Cataract
• Corneal perforations

This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off the extra liquid.

Arogat-P Eye Drop is a combination of two medicines. Gatifloxacin is an antibiotic that works by stopping the action of a bacterial enzyme called DNA-gyrase. This prevents the bacterial cells from dividing and repairing, thereby killing them. Prednisolone is a steroid which works by blocking the production of certain chemical messengers in the body that cause inflammation (redness and swelling) and allergies. This how it works to treat bacterial eye infections.

• Arogat-P Eye Drop must be used as per dose and duration suggested by the doctor.
• If you wear soft contact lenses, remove them before putting in these eye drops and wait at least 15 minutes before putting your lenses back in.
• Wait for at least 5-10 minutes before delivering the next medication in the same eye to avoid dilution.
• Arogat-P Eye Drop might cause blurring of vision. Do not drive or operate machinery until you know how the medicine affects you.
• Avoid contact with your nose or mouth. Rinse it off with water if you accidentally get the drop in these areas.

Gatifloxacin. Allergan, Inc.; 1999 [revised 2010]. [Accessed 17 Apr. 2019] (online) Available from:

ScienceDirect. Prednisolone. [Accessed 17 Apr. 2017] (online) Available from:

Drugs.com. Gatifloxacin. [Accessed 17 Apr. 2017] (online) Available from:

PubChem. Prednisolone. [Accessed 17 Apr. 2017] (online) Available from: